Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Issued
Ratios

ProPhase Labs (PRPH) Shares Outstanding (2016 - 2023)

Historic Shares Outstanding for ProPhase Labs (PRPH) over the last 14 years, with Q2 2023 value amounting to $16.8 million.

  • ProPhase Labs' Shares Outstanding rose 713.74% to $16.8 million in Q2 2023 from the same period last year, while for Jun 2023 it was $16.8 million, marking a year-over-year increase of 713.74%. This contributed to the annual value of $16.2 million for FY2022, which is 468.09% up from last year.
  • Per ProPhase Labs' latest filing, its Shares Outstanding stood at $16.8 million for Q2 2023, which was up 713.74% from $16.9 million recorded in Q1 2023.
  • ProPhase Labs' 5-year Shares Outstanding high stood at $11.6 billion for Q1 2020, and its period low was $11.6 million during Q1 2019.
  • Moreover, its 5-year median value for Shares Outstanding was $15.3 million (2021), whereas its average is $656.8 million.
  • In the last 5 years, ProPhase Labs' Shares Outstanding soared by 10011852.29% in 2020 and then crashed by 9986.92% in 2021.
  • ProPhase Labs' Shares Outstanding (Quarter) stood at $11.6 million in 2019, then increased by 0.26% to $11.6 million in 2020, then surged by 33.45% to $15.5 million in 2021, then grew by 4.68% to $16.2 million in 2022, then increased by 3.91% to $16.8 million in 2023.
  • Its Shares Outstanding stands at $16.8 million for Q2 2023, versus $16.9 million for Q1 2023 and $16.2 million for Q4 2022.